In addition, our findings reveal a poorer prognosis in individuals with high S100 scores amongst ALL patients, thus corroborating previous literature citing that the downregulation of S100A6 expression via amlexanox can effectively reduce resistance to TNFα and impairs tumor growth in KMT2A/ aff1-positive ALL [51]. This evidence concerns the gene S100A1 and acute lymphoblastic leukemia.